Breast Cancer Screening Market is likely to reach more than 20 Billion by the year 2018

ROSWELL, Ga. - April 15, 2015 - PRLog -- • Breast cancer mammography screening population share is mainly dominated by larger women populous countries such as United States, China and Brazil.

 • It is predicted that by 2018, slightly less than a Million Swiss women will visit for mammography screening.

 • In 2013, more than 10,000 Thousand women has gone for breast cancer mammography screening in United Kingdom.

 • It is anticipated that by 2018, India, United States and China  together will hold nearly 60 percent share of the total worldwide MRI & ultrasound population.

 • United States is the leading market for breast cancer screening.

Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of breast cancer cases.  Worldwide Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market are also growing year on year.

Worldwide Breast Cancer Screening population is expected to be little less than 250 Million by 2018. For 2013; China contributes the largest pool of patients followed by United States. Both these countries control double digit population share. Brazil, Japan and Germany occupy the 3rd, 4th, & 5th position respectively.

This is our 4th report on Cancer Sector. Renub Research study titled “Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide” analyzes the worldwide market for breast cancer mammography screening market, Breast cancer MRI screening market and breast cancer ultrasound screening market. This report studies separate comprehensive analytics for the 20 countries: United States, Canada, European Countries (United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland), Asian countries (India, China, Japan, Korea, Singapore, Thailand, Malaysia and Brazil), Australia and New Zealand.

Annual estimates and forecast are provided for the period of 2014 through 2018. A six year historic analysis is also provided for these markets. This 258 page report with 252 Figures and 14 Tables provides a complete analysis of top 20 countries of worldwide breast cancer screening market. All the 20 countries in the report have been studied from 7 viewpoints.

•Countries Breast Cancer Mammography Screening Population Scenario and Forecast
•Countries Breast Cancer MRI & Ultrasound Screening Population Scenario and Forecast
•Countries Breast Cancer Mammography Screening Market and Forecast
•Countries Breast Cancer MRI Screening Market and Forecast
•Countries Breast Cancer Ultrasound Screening Market and Forecast
•Countries Breast Cancer Screening Market and Forecast
•Worldwide Breast Cancer Screening Market and Forecast


All the 20 Countries Studied In the Report are as Follows

1.United States
2.Canada
3.United Kingdom
4.France
5.Germany
6.Italy
7.Spain
8.Netherlands
9.Norway
10.Switzerland
11.India
12.China
13.Japan
14.Koria
15.Singapore
16.Thailand
17.Malaysia
18.Brazil
19.Australia
20.New Zealand

Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.


Contact Us

Rajat Gupta
Sr. Manager
Sales & Marketing Div
Renub Research
Email: rajat.gupta@renub.com
Phone:  +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)